CPS Technologies (CPSH) Q4 2025: Facility Expansion Unlocks Capacity as Gold Costs Pressure Margins
CPS Technologies capped 2025 with record sales and a strategic pivot toward facility expansion, as rising gold prices diluted gross margins despite surging demand. Management’s focus now shifts to executing a complex relocation, which is expected to resolve revenue constraints and enable new product commercialization. With capital in hand and operational bottlenecks addressed, CPSH enters 2026 positioned for both margin recovery and broader market access.
Summary
- Facility Move to Drive Growth: Relocation will address production bottlenecks and enable higher output.
- Margin Pressure from Gold Costs: Soaring gold prices and inventory build weighed on Q4 profitability.
- Tech Portfolio Expansion: New defense and research programs set the stage for longer-term upside.
Performance Analysis
CPS Technologies delivered its strongest revenue year on record, closing 2025 with $32.6 million in sales and a Q4 revenue of $8.2 million, up from $5.9 million in the prior year’s quarter. The company’s expanded third shift and improved production throughput drove this performance, though Q4 saw a sequential dip due to customer holiday slowdowns, especially overseas.
Gross profit rebounded year-over-year, but Q4 margins compressed to 14.6% due to two main factors: the rapid rise in gold prices, which directly impacts the cost of gold-plated products, and the build-up of inventory ahead of the planned facility move. SG&A spending remained disciplined, supporting a near break-even operating result despite margin headwinds. The company’s balance sheet was fortified by a $9.5 million capital raise, leaving CPSH with $4.5 million in cash and $8.8 million in marketable securities to fund its growth agenda.
- Operational Leverage from Third Shift: Additional production capacity underpinned higher shipments and revenue expansion.
- Gold Price Surge Drove Margin Dilution: Gold input costs, now a material expense, eroded incremental profitability for gold-plated products.
- Inventory Build as Move Buffer: Elevated inventory levels serve as a cushion to minimize customer impact during the upcoming facility transition.
While profitability remains modest, the year’s results reflect a company in transition—balancing strong demand with the realities of input cost inflation and the logistical complexity of a major site move.
Executive Commentary
"We continue to benefit from strong underlying demand and are well on our way to selecting a new site to expand and improve our production capabilities... With our newly strengthened balance sheet, we are clearly in better shape than at any time in recent memory, and we expect 2026 to position our company very well for higher growth going forward."
Brian Mackey, President and CEO
"Margins in Q4 took a step down versus Q3 due to the reduction in revenue as well as the dilutive impact on margins of the dramatically increased cost of gold... Going forward, we expect margins to expand as we continue to implement improvements to our operations, notwithstanding any short-term impacts when we move production at the appropriate time."
Chuck Griffith, Chief Financial Officer
Strategic Positioning
1. Facility Relocation as Growth Catalyst
CPSH’s current facility is now a revenue constraint, with space limitations capping output despite strong demand. The planned move—funded by the recent capital raise and guided by Dacon Corporation—will unlock floor space, allow for targeted equipment additions, and enable higher production volumes. Management expects operational efficiencies, lower maintenance costs, and a better work environment post-move, with minimal workforce disruption due to proximity.
2. Margin Management Amid Commodity Volatility
Gold price inflation has become a significant margin headwind, as many CPSH products require gold plating. The company has limited ability to pass these costs through, especially on fixed-price contracts, resulting in nominal margin contribution on the gold component. Inventory build ahead of the move further pressured margins in Q4, but management anticipates a reversal as inventory is drawn down during the transition.
3. Defense and Research Pipeline Expansion
Hybrid tech armor and advanced materials programs are set to benefit from renewed U.S. defense funding and ongoing Department of Energy support. The passage of the FY26 defense bill is expected to restart Navy orders in the second half of 2026, while the company’s SBIR and STTR research contracts remain active and funded. Recent investments in ALMAX, ceramic fiber processing, and tungsten alloy sintering position CPSH for future market entry and IP moat development.
4. Customer and Product Diversification
Core demand from major customers remains robust, with contract renewals and validation efforts underway for new large accounts. The facility move is expected to provide the capacity and flexibility needed to capture additional business, including emerging opportunities in radiation shielding and advanced ceramics.
Key Considerations
This quarter marks a pivotal operational and strategic inflection, as CPSH transitions from capacity-constrained execution to a more scalable, innovation-driven model. Investors should weigh near-term disruption against the longer-term upside from expanded capabilities and new product commercialization.
Key Considerations:
- Relocation Execution Risk: The facility move is operationally complex and could disrupt production if not carefully managed, though management is stockpiling inventory to buffer customers.
- Margin Recovery Potential: Margin headwinds from gold prices and inventory build are likely transient, with improvement expected post-move and as new product lines scale.
- Defense Contract Visibility: Resumption of Navy orders and progress in Army-funded tungsten programs could meaningfully expand the addressable market, but timing and volume remain uncertain.
- Capital Allocation and Cash Burn: The strengthened balance sheet provides flexibility, but ongoing investments in equipment and relocation will consume cash through 2026.
Risks
Execution risk is elevated during the facility transition, with potential for production downtime or customer delivery delays. Commodity price volatility, especially gold, remains a margin threat unless costs can be passed through or hedged. Defense and government research funding cycles introduce timing and contract risk, while new product commercialization timelines are inherently uncertain. Investors should monitor for any slippage in move timing, cost overruns, or unexpected demand disruptions.
Forward Outlook
For Q1 2026, CPSH guided to:
- Solid revenue performance, supported by backlog and ongoing customer demand.
- Continued margin pressure in the short term, with improvement expected following the facility move.
For full-year 2026, management maintained a constructive outlook:
- Revenue growth as expanded capacity comes online and new contracts are secured.
- Margin expansion initiatives to be implemented post-move, with additional upside from defense and research programs.
Management highlighted several factors that will shape the year:
- Timing and smooth execution of the facility relocation.
- Resumption and ramp of Navy and Army defense orders.
Takeaways
CPSH enters 2026 with clear operational momentum, a fortified balance sheet, and a path to resolve legacy capacity constraints. The next phase hinges on successful relocation, margin stabilization, and defense contract execution.
- Facility Move as Inflection Point: The new site is the linchpin for unlocking higher revenue, margin recovery, and product diversification.
- Margin Headwinds Are Likely Transitory: Gold costs and inventory build are expected to ease as operational changes take effect.
- Defense and Research Pipeline Could Drive Upside: Progress in Navy, Army, and DOE-funded projects provides optionality for future growth, but requires continued execution and contract wins.
Conclusion
CPS Technologies closed a record year by addressing its most pressing constraint—production space. The planned facility move, supported by ample liquidity, sets the stage for margin improvement and product expansion in 2026 and beyond. Investors should focus on the execution of this transition and the ramp of new defense and research contracts as the next phase of value creation.
Industry Read-Through
CPSH’s experience reflects broader trends in specialty manufacturing, where capacity constraints and input cost volatility are forcing capital investment and operational change. The company’s heavy exposure to gold costs is a cautionary signal for peers with similar material dependencies. Defense and federally funded R&D remain robust sources of demand, but timing and regulatory cycles can introduce lumpiness. For advanced materials and defense suppliers, facility flexibility and the ability to quickly commercialize new technologies are emerging as key competitive differentiators.